| Oncotelic Therapeutics, Inc. (OTLC) |
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 |
| Balance Sheet Date | | | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | | | | | | | | | | | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 |
| Fiscal Period | | | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | | | | | | | | | | | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 |
| Close Price of Common Stock | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Market Cap of Common Stock | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Warrant | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Unit | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Right | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Shares Outstanding | 444,197,032 | | 442,596,856 | 439,446,318 | 408,292,720 | 408,292,720 | 407,289,618 | 407,289,618 | 407,289,618 | 399,684,128 | 399,184,128 | 398,159,128 | 397,531,590 | 392,871,880 | 391,846,880 | | | | 375,288,146 | | 369,696,959 | 369,446,959 | 90,601,912 | 89,601,912 | 88,601,912 | 88,032,112 | 84,069,967 | 83,469,967 | 83,469,967 | 41,420,000 | 6,843,802 | 41,420,000 | 41,420,000 | 26,545,000 | 26,545,000 | 26,545,000 | 26,545,000 | 26,545,000 | 26,545,000 | 26,545,000 | 26,545,000 | 26,545,000 | 26,545,000 | 26,545,000 | 26,545,000 | 26,545,000 | 20,705,000 | 20,706,000 | 20,702,000 |
| QoQ% | | | .72% | 7.63% | .00% | .25% | .00% | .00% | 1.90% | .13% | .26% | .16% | 1.19% | .26% | | | | | | | .07% | 307.77% | 1.12% | 1.13% | .65% | 4.71% | .72% | .00% | 101.52% | 505.22% | (83.48%) | .00% | 56.04% | .00% | .00% | .00% | .00% | .00% | .00% | .00% | .00% | .00% | .00% | .00% | .00% | 28.21% | (.01%) | .02% | 35.36% |
| YoY% | 8.79% | | 8.67% | 7.90% | .25% | 2.15% | 2.03% | 2.29% | 2.46% | 1.73% | 1.87% | | | | 4.41% | | | | 314.22% | | 317.26% | 319.67% | 7.77% | 7.35% | 6.15% | 112.54% | 1,128.41% | 101.52% | 101.52% | 56.04% | (74.22%) | 56.04% | 56.04% | .00% | .00% | .00% | .00% | .00% | .00% | .00% | .00% | .00% | 28.21% | 28.20% | 28.22% | 73.57% | 270.66% | 590.43% | 810.38% |